Priel Meir

2 papers in the library · 48 citations · publishing 2022-2023

Papers

Sort Most recent Most cited

Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.

Journal of Affective Disorders February 15, 2023 Priel Meir, Leslie Taylor, Jair C Soares et al. 25 citations

Despite psychedelic research initially ceasing in the 1970-80s, the findings documented encouraged researchers to re-examine the safety and efficacy of treating mental health with psychedelics. Of particular focus, psilocybin has shown to have therapeutic potential for a variety of mental health problems and was granted breakthrough therapy status by the FDA. Should psilocybin eventually become...

DOI: 10.1016/j.jad.2022.12.050 Full text Psychedelic-assisted therapy Barriers to treatment Mental health professionals Psilocybin-assisted therapy +5

Magic Mushrooms – an exploratory look at how mental health professionals feel and think about Psilocybin

Psychiatry Research July 16, 2022 Thomas D Meyer, Priel Meir, Claudia Lex et al. 23 citations

Psilocybin recently received breakthrough status by the FDA for its use in treatment of depression. We therefore investigated mental health professionals' (MHPs) opinions on Psilocybin (n = 155). Overall, attitudes were neutral but self-rated knowledge of Psilocybin was low. The term used in the survey, 'Psilocybin' or 'Magic Mushrooms', did not significantly affect their responses. Some...

DOI: 10.1016/j.psychres.2022.114727 Psilocybin Hallucinogen Mental health Exploratory research +2